Versant Ventures

Versant Ventures related stories

All articles and analysis

• 
  Groove Biopharma Raises $6 Mln

  Luisa Beltran- 12 December 2011

  Groove Biopharma has raised $6 million in series B financing from Alexandria Venture Investments, ARCH Venture Partners, OVP Venture Partners, Versant Ventures, and WRF Capital. Seattle-based Groove Biopharma is a privately held biotech.

• 
  Slideshow: Where the Biotech & Device Investors Are--Q4 Edition

  Jonathan Marino- 8 December 2011
• 
  Healthy Outlook for Health Services

  Staff Writer- 1 December 2011

  VCs are optimistic about the sector, thanks to a projected increase in spending

• 
  AcuFocus Inks $65 Million

  Angela Sormani- 30 November 2011
• 
  Advanced ICU Care Closes Funding Round

  Angela Sormani- 30 November 2011
• 
  Versant, Celgene, to Pair Up for Early-Stage Cancer Drug Deals--CORRECTED

  Jonathan Marino- 4 November 2011
• 
  M&A Is Heating up; Here Are the Top 10 VC-Backed M&A Deals for Q3 (slideshow)

  Sandeep Khare- 2 November 2011
• 
  M&A Is Heating up; Here Are the Top 10 VC-Backed M&A Deals for Q3 (slideshow)

  Lawrence Aragon- 2 November 2011
• 
  VCs Back Obama, Romney Campaigns; One Likes “Obamney”

  Joanna Glasner- 27 October 2011
• 
  Panmira Gets New CEO

  Angela Sormani- 18 October 2011

  Panmira Pharmaceuticals has appointed Hari Kumar as chief executive officer. Panmira was spun out of Amira Pharmaceuticals prior to Amira's acquisition by Bristol-Myers Squibb. Investors include Dr. Brad Bolzon (Versant Ventures), Mr. Kevin Kinsella (Avalon Ventures), Dr. David Schnell (Prospect Venture Partners) and Dr. Heath Lukatch (Novo A/S).